Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Finasteride alone increases suicide risk, but combining it with other treatments reduces this risk.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

The FDA approved using Cialis with Proscar for better treatment options.

Persistent ED in Propecia users is not due to abnormal blood flow.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.